649
Views
66
CrossRef citations to date
0
Altmetric
Inflammatory bowel disease

Malignancies in patients with inflammatory bowel disease: a nationwide register study in Finland

, , &
Pages 1405-1413 | Received 27 Jun 2013, Accepted 15 Sep 2013, Published online: 16 Oct 2013
 

Abstract

Objective. Patients with inflammatory bowel disease (IBD) are at increased risk of certain cancers. We assessed the long-term risks of malignancies among patients with IBD in Finland. Methods. A total of 21,964 patients with IBD (16,649 with UC and 5315 with CD) from the database of the Social Insurance Institution were diagnosed in the periods 1987–1993 and 2000–2007 and followed up to the end of 2010 in a linkage with the nationwide Finnish Cancer Registry. The numbers of cancers observed were compared to those expected in general population and expressed as a standardized incidence ratio (SIR). Results. Overall, male patients with CD and UC had a slightly increased risk of malignancies. Patients with UC were found to have an increased risk of colon (SIR 1.81, 95% confidence interval 1.46–2.21), rectal (1.76, 1.35–2.25), biliary tract (7.26, 4.37–11.1), and thyroid cancers (1.93, 1.28–2.79). The risk of colorectal cancer (CRC) was highest among the youngest UC patients. Patients with CD had a significantly increased SIR for cancers of the small intestine (9.97, 4.30–19.6), anus (9.51, 1.96–27.8), and biliary tract (4.93, 1.02–14.4), and also for myeloma (2.84, 1.14–5.85). In addition, the risk of basal cell skin cancer was increased in IBD (1.29, 1.16–1.43). Males with UC had a slightly decreased risk of lung and prostate cancers. Conclusions. The incidence of cancer among male patients with CD and CU was higher than that in general population. Patients with UC are at increased risk for CRC and biliary tract cancers. CRC risk was highest in the youngest patients.

Acknowledgements

This study was financially supported by the Finnish Foundation for Gastroenterological Research, The Hospital District of South Ostrobothnia, Finland and the Competitive Research Funding of the Pirkanmaa Hospital District, Finland (9P008). The sponsors did not have any involvement in study design, collection, analysis, interpretation, writing, or submission of the manuscript.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.